Cone rod dystrophies.

Hamel CP. · 2007

Read Cone rod dystrophies. by Hamel CP. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1808442.txt.

Introduction

Hamel reviewed cone rod dystrophies in 2007, a group of inherited eye diseases affecting about one person in 40,000. The retina is the light-sensing layer at the back of the eye. In these diseases the cone cells, which give sharp central and color vision, fail first.

That order is the reverse of typical retinitis pigmentosa, where rod cells for night vision go first. Early signs are falling sharpness, color defects, dislike of bright light, and loss of central vision. Peripheral vision and night sight fade later, and the course is usually faster and harsher than in rod-first disease. Most cases stand alone, though some join syndromes such as Bardet Biedl syndrome. Ten cloned genes and three further loci were known, led by ABCA4, CRX, and GUCY2D.

Catalog record

CREATORHamel CP.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1808442

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Cone rod dystrophies By Christian P Hamel Published in: Orphanet Journal of Rare Diseases DOI: 10.1186/1750-1172-2-7 ABSTRACT Cone rod dystrophies (CRDs) (prevalence 1/40,000) are inherited retinal dystrophies that belong to the group of pigmentary retinopathies. CRDs are characterized by retinal pigment deposits visible on fundus examination, predominantly localized to the macular region. In contrast to typical retinitis pigmentosa (RP), also called the rod cone dystrophies (RCDs) resulting from the primary loss in rod photoreceptors and later followed by the secondary loss in cone photoreceptors, CRDs reflect the opposite sequence of events. CRD is characterized by primary cone involvement, or, sometimes, by concomitant loss of both cones and rods that explains the predominant symptoms of CRDs: decreased visual acuity, color vision defects, photoaversion and decreased sensitivity in the central visual field, later followed by progressive loss in peripheral vision and night blindness. The clinical course of CRDs is generally more severe and rapid than that of RCDs, leading to earlier legal blindness and disability. At end stage, however, CRDs do not differ from RCDs. CRDs are most frequently non syndromic, but they may also be part of several syndromes, such as Bardet Biedl syndrome and Spinocerebellar Ataxia Type 7 (SCA7). Non syndromic CRDs are genetically heterogeneous (ten cloned genes and three loci have been identified so far). The four major causative genes involved in the pathogenesis of CRDs are ABCA4 (which causes Stargardt disease and also 30 to 60% of autosomal recessive CRDs), CRX and GUCY2D (which are responsible for many reported cases of autosomal dominant CRDs), and RPGR (which causes about 2/3 of X-linked RP and also an undetermined percentage of X-linked CRDs). It is likely that highly deleterious mutations in genes that otherwise cause RP or macular dystrophy may also lead to CRDs. The diagnosis of CRDs is based on clinical history, fundus examination and electroretinogram. Molecular diagnosis can be made for some genes, genetic counseling is always advised. Currently, there is no therapy that stops the evolution of the disease or restores the vision, and the visual prognosis is poor. Management aims at slowing down the degenerative process, treating the complications and helping patients to cope with the social and psychological impact of blindness. DISEASE NAME Cone rod dystrophies (CRDs) Definition and diagnosis criteria CRDs are inherited retinal dystrophies that belong to the pigmentary retinopathies group. Functional signs and symptoms • Decrease in the visual acuity is the earliest symptom • Photophobia also occurs early • Frequent dyschromatopsia • Night blindness occurs later Visual field • Central scotoma appears first, preventing fluent reading • Patchy losses of peripheral vision follow • Severe loss of vision occurs earlier than in retinitis pigmentosa (RP) Fundus • Normal looking macula or fine macular lesions and pallor of the optic disc may be the only signs at early stage • Pigmentary deposits resembling bone spicules, frequently in macular area • Attenuation of the retinal vessels • Waxy pallor of the optic disc • Various degrees of retinal atrophy Electroretinogram (ERG) • Implicit time (between a- and b-wave peaks) shift at the 30-Hz flicker responses, along with delayed a- and b-wave single flash photopic response are early signs before amplitude reduction • Dramatic decrease of amplitudes of both a- and b-waves • Predominant involvement of photopic (cones) over scotopic (rods) responses EPIDEMIOLOGY Prevalence of CRDs is estimated at 1/40,000 (thus, CRDs are ten times less frequent than RP) [1]. Clinical description Non syndromic cone rod dystrophies CRDs present first as a macular disease or as a diffuse retinopathy with predominance of the macular involvement. In contrast to the symptoms of the rod cone dystrophies (RCDs, typical retinitis pigmentosa) resulting from predominant rod involvement, i.e. night blindness and loss of peripheral vision, the clinical signs of CRDs reflect the predominant involvement of cones, which leads to decreased visual acuity and loss of sensitivity in the central visual field. This fits the original description of the CRD entity in which cone loss precedes rod degeneration. However, in some cases, diffuse retinopathy affects simultaneously cones and rods, resulting in both night blindness and loss of visual acuity. These cases may also be considered as CRDs, although they overlap with other entities (see differential diagnosis). In general, CRDs are more severe than RCDs because the loss of patients' autonomy occurs earlier. It is convenient to describe two stages in the disease course of CRD. In the first stage, the main symptom is decreased visual acuity, which is usually discovered at school, in the first decade of life, and which does not significantly improve with spectacles. Patients often have a noticeable deviated gaze to project images on parafoveal regions of their retina that are less damaged. Along with this symptom, there are intense photophobia and a variable degree of dyschromatopsia. In contrast, night blindness is not mentioned by patients or, when present, is never as prominent as the decrease in visual acuity. Visual field testing shows central scotomas, while periphery is spared. As a result, patients have no difficulties to move. Fundus examination shows pigment deposits and various degrees of retinal atrophy in the macular region (Figure 1). Retinal vessels are usually normal or moderately attenuated. The optic disc is often pale at early stages, particularly on the temporal side, which accounts for the macular fibre bundle. At this stage, the question is to differentiate CRDs from macular dystrophies such as Stargardt disease, cone dystrophies and other rare macular conditions. Additional investigations help the diagnosis. First, fluorescein angiography and fundus autofluorescence show that the peripheral retina is also involved with heterogeneity in the fluorescence, but to a lesser extent than the macula. Second, the electroretinogram (ERG) shows a shift in implicit time of cone responses, followed by a decrease in both cone and rod responses. Cone responses are more severely affected than rod responses. [Figure: Fundus of a 45 year-old patient with cone rod dystrophy segregating with a loss-of-function mutation (E1087X) in ABCA4. Note the presence of various-shaped pigment deposits in the posterior pole with atrophy of the retina, while the retina appears less damaged in periphery (upper part of the photograph).] In the second stage, night blindness becomes more apparent and the loss in the peripheral visual field progresses. Therefore, patients have difficulties to move autonomously. In addition, visual acuity continues to decrease to a level where reading is no longer possible. Nystagmus is often present. At this stage, patients are legally blind (visual acuity <1/20), even though large parts of the peripheral visual field remain preserved. Syndromic cone rod dystrophies There are a few syndromes in which retinal degeneration characteristically features CRDs rather than typical RP. • Bardet Biedl syndrome (BBS) is an autosomal recessive disease with a prevalence ranging from 1/13,500 to 1/60,000. It associates retinal dystrophy with postaxial polydactyly, obesity, hypogenitalism, mental retardation or mild psychomotor delay, and renal abnormalities that can lead to renal failure. The retinal dystrophy is classically described as a RCD but many variants have been reported with a prominent macular involvement (Figure 2), indicating a CRD [2]. In fact, BBS patients have the diffuse type of CRD. In our experience, they always have macular involvement, with decreased visual acuity, photophobia and foveomacular hyperfluorescence on fluorescein angiography. The diagnosis of

Read the complete text